Matches in Wikidata for { <http://www.wikidata.org/entity/Q66027455> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66027455 description "clinical trial" @default.
- Q66027455 description "ensayu clínicu" @default.
- Q66027455 description "klinisch onderzoek" @default.
- Q66027455 description "клінічне випробування" @default.
- Q66027455 name "VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil" @default.
- Q66027455 name "VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil" @default.
- Q66027455 type Item @default.
- Q66027455 label "VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil" @default.
- Q66027455 label "VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil" @default.
- Q66027455 prefLabel "VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil" @default.
- Q66027455 prefLabel "VALORY Study of Valsartan/Hydrochlorizide for Patients Who do Not Respond Adequately to Olmesartan Medoxomil" @default.
- Q66027455 P1050 Q66027455-63027739-2C17-43E1-85EC-814368047AEC @default.
- Q66027455 P1132 Q66027455-77A0B439-BAAB-4AA0-A550-16ED5A193E0D @default.
- Q66027455 P1476 Q66027455-F513066B-DD7A-447E-8458-68C5548DDE81 @default.
- Q66027455 P17 Q66027455-6D90847D-8998-4157-B7E3-1E09CED34A39 @default.
- Q66027455 P17 Q66027455-DEF12D2C-F2BB-4FE9-9D54-21C4981F6860 @default.
- Q66027455 P2899 Q66027455-11C64362-C17E-49C2-B90F-754534C60ACA @default.
- Q66027455 P3098 Q66027455-F1ABD551-7C8B-4817-990E-D278AB1AE1E3 @default.
- Q66027455 P31 Q66027455-260B7E4A-43AC-4B29-98F9-E48A97E26470 @default.
- Q66027455 P4844 Q66027455-6E594166-D76E-4C1F-AA7F-09B5CEB89EC0 @default.
- Q66027455 P580 Q66027455-FAD4F166-95B7-4AD7-B9E3-625BCB1A88BF @default.
- Q66027455 P582 Q66027455-392A7BB5-393D-4713-BA6A-964259E415C2 @default.
- Q66027455 P6099 Q66027455-EAF2CECF-DED7-40CE-9DFA-7A0E2B965DD4 @default.
- Q66027455 P6153 Q66027455-70FD2BC4-5860-49D4-8DAA-3C79D68AA872 @default.
- Q66027455 P8363 Q66027455-E10C411C-8B9B-4ED8-9D86-A8E5880D4C22 @default.
- Q66027455 P1050 Q41861 @default.
- Q66027455 P1132 "+212" @default.
- Q66027455 P1476 "An Open,Multicenter Study to Evaluate the Efficacy and Safety of a 4 Week Therapy With Valsartan/Hydrochlorothiazide 160/25 (Fixed Dose Combination of Valsartan 160 mg Plus HCTZ 25 mg) in Patients Not Adequately Responding to a 4 Week Monotherapy With Olmesartan Medoxomil 40 mg or Combination Therapy With Olmesartan Medoxomil 20 mg Plus HCTZ 12.5 mg" @default.
- Q66027455 P17 Q183 @default.
- Q66027455 P17 Q39 @default.
- Q66027455 P2899 "+18" @default.
- Q66027455 P3098 "NCT00171015" @default.
- Q66027455 P31 Q30612 @default.
- Q66027455 P4844 Q7912612 @default.
- Q66027455 P580 "2004-12-01T00:00:00Z" @default.
- Q66027455 P582 "2005-04-01T00:00:00Z" @default.
- Q66027455 P6099 Q42824827 @default.
- Q66027455 P6153 Q507154 @default.
- Q66027455 P8363 Q78089383 @default.